Condition
Prodromal Stage
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting2
Not Yet Recruiting1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07324330Not ApplicableRecruiting
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
NCT06993142Not ApplicableNot Yet Recruiting
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
NCT06193252Not ApplicableRecruiting
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
NCT03738046Not ApplicableWithdrawn
HOPE TEAM - Clinical High Risk Group CBSST
Showing all 4 trials